Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/15/2000 | CA2353797A1 Neuron-associated proteins |
06/15/2000 | CA2353773A1 Cark protein and nucleic acid molecules and uses therefor |
06/15/2000 | CA2353701A1 Method for detecting the presence of stem cells utilizing a detectable substrate for aldehyde dehydrogenase (aldh) |
06/15/2000 | CA2353578A1 Application of shear flow stress to smooth muscle cells for the production of implantable structures |
06/15/2000 | CA2353525A1 Drug targets in candida albicans |
06/15/2000 | CA2352534A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains |
06/15/2000 | CA2349404A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells |
06/14/2000 | EP1008603A1 Soluble polypeptides |
06/14/2000 | EP1008351A1 Carcinostatic agents |
06/14/2000 | EP1007743A2 Enzymes mixture |
06/14/2000 | EP1007720A1 Dendritic cell hybrids |
06/14/2000 | EP1007717A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
06/14/2000 | EP1007716A1 Use of lentiviral vectors for antigen presentation in dendritic cells |
06/14/2000 | EP1007715A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
06/14/2000 | EP1007714A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof |
06/14/2000 | EP1007713A2 Dna expression in transfected cells and assays carried out in transfected cells |
06/14/2000 | EP1007712A1 The use of mixed duplex oligonucleotides to effect localized genetic changes in plants |
06/14/2000 | EP1007711A1 Für drosomycin kodierendes chimäres gen, dieses gen enhaltender vektor und herstellung von krankheitsresistenten transgenen pflanze |
06/14/2000 | EP1007710A1 A sunflower albumin 5' regulatory region for the modification of plant seed lipid composition |
06/14/2000 | EP1007709A1 Pathogen-induced plant promoters |
06/14/2000 | EP1007708A1 Sense intron inhibition of starch branching enzyme expression |
06/14/2000 | EP1007706A1 Rna binding protein and binding site useful for expression of recombinant molecules |
06/14/2000 | EP1007702A1 Method for increasing the gene expression of saccharose synthase |
06/14/2000 | EP1007700A1 Immunological detection of prions |
06/14/2000 | EP1007697A2 Production of proteins in eggs |
06/14/2000 | EP1007696A1 Il-13 receptor specific chimeric proteins and uses thereof |
06/14/2000 | EP1007695A2 Rab proteins |
06/14/2000 | EP1007693A1 Pak kinase genes and polypeptides and methods of use thereof |
06/14/2000 | EP1007691A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
06/14/2000 | EP1007687A1 Fiv vaccine |
06/14/2000 | EP1007684A2 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth |
06/14/2000 | EP1007683A1 Coffee storage proteins |
06/14/2000 | EP1007682A1 Novel nucleic acid molecules and uses therefor |
06/14/2000 | EP1007681A1 Method of increasing the iron content of plant cells |
06/14/2000 | EP1007679A1 Recombinant human erythropoietin with advantageous glycosylation profile |
06/14/2000 | EP1007678A1 Kringle1 |
06/14/2000 | EP1007674A1 Testis-specific transcription factor zgcl-1 |
06/14/2000 | EP1007673A1 Novel bone mineralization proteins, dna, vectors, expression systems |
06/14/2000 | EP1007672A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
06/14/2000 | EP1007671A1 Fanconi-gen ii |
06/14/2000 | EP1007670A2 Two human g-protein coupled receptors: ebv-induced gpcr 2 (ebi-2) and edg-1-like gpcr |
06/14/2000 | EP1007668A1 Human pancreatitis-associated protein, pap-2 |
06/14/2000 | EP1007666A1 Neurturin receptor |
06/14/2000 | EP1007665A1 Two human homologues of galectin-5 |
06/14/2000 | EP1007663A2 Human proteins |
06/14/2000 | EP1007662A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio |
06/14/2000 | EP1007660A2 Secreted proteins and polynucleotides encoding them |
06/14/2000 | EP1007659A2 Tumor necrosis factor receptors 6 alpha & 6 beta |
06/14/2000 | EP1007650A1 Pca3, pca3 genes, and methods of use |
06/14/2000 | EP1007647A1 High level of expression of ingap |
06/14/2000 | EP1007645A1 Human serum inducible kinase (snk) |
06/14/2000 | EP1007643A2 1-alpha-hydroxylase |
06/14/2000 | EP1007639A1 GLUCOSE RESPONSIVE $g(b)-CELL LINE |
06/14/2000 | EP1007638A1 Kcnq potassium channels and methods of modulating same |
06/14/2000 | EP1007637A1 Methods for increasing the efficiency of recombinant aav product |
06/14/2000 | EP1007636A2 Cultures of human cns neural stem cells |
06/14/2000 | EP1007635A1 Agent for dehydrating corneas in organ culture |
06/14/2000 | EP1007634A1 Encapsulation of living tissue cells in a microsphere |
06/14/2000 | EP1007633A1 Avian primordial germ cell (pgc) cell line and a method for long term culturing thereof |
06/14/2000 | EP1007632A1 Isolation of bone and cartilage precursor cells |
06/14/2000 | EP1007631A1 Cardiac muscle regeneration using mesenchymal stem cells |
06/14/2000 | EP1007630A1 Natural killer cell lines and methods of use |
06/14/2000 | EP1007629A2 Sugar cane production |
06/14/2000 | EP1007627A1 Novel extracellular serine protease |
06/14/2000 | EP1007565A2 Transgenic animals with disrupted npy y1 receptor genes |
06/14/2000 | EP1007563A1 Hm74a receptor |
06/14/2000 | EP1007562A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e |
06/14/2000 | EP1007551A2 Vaccine against hpv |
06/14/2000 | EP1007550A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF $i(EHRLICHIA) INFECTION |
06/14/2000 | EP1007549A1 Compositions and methods for highly efficient transfection |
06/14/2000 | EP1007540A1 Dna molecules encoding human nuclear receptor proteins |
06/14/2000 | EP1007539A1 Secreted proteins and polynucleotides encoding them |
06/14/2000 | EP1007535A1 Methods and compositions for diagnosis and treatment of breast cancer |
06/14/2000 | EP1007534A1 Bh3 interacting domain death agonist |
06/14/2000 | EP1007095A2 Chimeric toxins for targeted therapy |
06/14/2000 | EP1007089A1 Anticoagulant agents useful in treatment of thrombosis |
06/14/2000 | EP1007088A1 Recombinant porcine adenovirus vector |
06/14/2000 | EP1007074A1 Hypothalamus-specific polypeptides |
06/14/2000 | EP1007069A1 Novel coding sequences |
06/14/2000 | EP1007064A1 Regeneration of nerves in the central nervous system |
06/14/2000 | EP1007063A1 Bone regeneration in osteoporosis using human bone marrow mesenchymal cells |
06/14/2000 | EP1006801A1 Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders |
06/14/2000 | EP1006797A1 Serpin enzyme complex receptor-mediated gene transfer |
06/14/2000 | EP1006796A1 Compositions and methods for administering borrelia dna |
06/14/2000 | EP1006784A1 Glutathione-s-conjugate transport in plants |
06/14/2000 | EP1006783A1 Shoot meristem specific promoter sequences |
06/14/2000 | EP1006782A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
06/14/2000 | EP1006780A1 Two component plant cell lethality methods and compositions |
06/14/2000 | EP0979293A4 Transcriptional silencing elements and their binding factors |
06/14/2000 | CN1256696A Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
06/14/2000 | CN1256635A Peptide-coated implants and methods for producing same |
06/14/2000 | CN1256632A Suppression of malignancy utilizing ribonucleotide reductase R1 |
06/14/2000 | CN1256310A Process for preparing fowl paralysis virus using continuous avian cell line |
06/14/2000 | CN1256309A Ephedra cell ZHJ-25 CGMCC No.0359 and its induction method |
06/14/2000 | CN1053468C Improvements in or relating to organic compounds |
06/13/2000 | US6075185 Synthetic DNA sequence having enhanced insecticidal activity in maize |
06/13/2000 | US6075184 Purified proteins, recombinant DNA sequences and processes for producing caffeine free beverages |
06/13/2000 | US6075136 Polynucleotide sequence coding a polypeptide with enzymatic activity; for treating or preventing cancer and reproductive defects; anticarciongenic agents |
06/13/2000 | US6075134 Glycoconjugates and methods |
06/13/2000 | US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents |